Prognostik Nutrisyonel İndeksin ve Enflamatuar Belirteçlerin Lokal İleri Evre Rektal Kanserli Yaşlı Hastalarda Sağkalımı Üzerine Etkisi

References

Bray F, Ferlay J, Soerjomataram I (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal For Clinicians 68(6),394-424

Norwegian Colorectal Cancer Registry, annual report 2015. https://www.kreftregisteret.no/globalassets/cancer-in-norway/2015/cin_2015.pdf, access time: 12.02.2022

Shahir MA, Lemmens VE, van de Poll-Franse LV, Voogd AC, Martijn H, Janssen-Heijnen ML (2016) Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study. European Journal of Cancer 42(17):3015–3021

Iseki Y, Shibutani M, Maeda K, Nagahara H, Ohtani H, Sugano K, Ikeya T, Muguruma K, Tanaka H, Toyokawa T, Sakurai K, Hirakawa K (2015) Impact of the preoperative controlling nutritional status (conut) score on the survival after curative surgery for colorectal cancer. PloS one, 10(7)

Tan CS, Read JA, Phan VH, Beale PJ, Peat JK, Clarke SJ (2015) The relationship between nutritional status, inflammatory markers and survival in patients with advanced cancer: a prospective cohort study. Supportive Care in Cancer 23(2):385–391

Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 85:1001-1005

Bozkaya Y, Köstek O, Sakin A, Özyükseler DT, Şakalar T, Çil İ (2020) Is the prognostic nutritional index a prognostic and predictive factor in metastatic non-small cell lung cancer patients treated with first-line chemotherapy? Supportive Care in Cancer 28(5):2273–2282. https://doi.org/10.1007/s00520-019-05055-x.

Küçükarda A, Erdoğan B, Gökyer A, Sayın S, Gökmen İ, Özcan E, Hacıoğlu MB, Uzunoğlu S, Çiçin İ (2022) Prognostic nutritional ındex and its dynamics after curative treatment are ındependent prognostic factors on survival in non-metastatic nasopharyngeal carcinoma. Supportive Care in Cancer. 30(3):2131-2139

Sun K, Chen S, Xu J, Li G, He Y (2014) The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis. Journal of cancer research and clinical oncology. 140(9):1537-1549

Duan YY, Deng J, Su DF, Li WQ, Han Y, Li ZX, Huan XZ, Zhu SH, Yang QL, Hu W, Xin MZ, Tang LQ, Mai H Q, Fan YY, He Y (2021) Construction of a comprehensive nutritional index and comparison of its prognostic performance with the PNI and NRI for survival in older patients with nasopharyngeal carcinoma: a retrospective study. Supportive Care in Cancer 1-11

Noh GT, Han J, Cho MS, Hur H, Min BS, Lee KY, Kim NK (2017) Impact of the prognostic nutritional index on the recovery and long-term oncologic outcome of patients with colorectal cancer. Journal of Cancer Research and Clinical Oncology 143(7):1235-1242

Ucar G, Ergun Y, Acikgoz Y, Uncu D (2020) The prognostic value of the prognostic nutritional index in patients with metastatic colorectal cancer. Asia‐Pacific Journal of Clinical Oncology. 16(5):179-184

Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867

Kim IH, Lee JE, Yang JH, Jeong JW, Ro S, Lee MA (2018) Clinical significance of changes in systemic inflammatory markers and carcinoembryonic antigen levels in predicting metastatic colorectal cancer prognosis and chemotherapy response. Asia‐pacific Journal of Clinical Oncology 14(3), 239-246

Ehrsson YT, Hellström PM, Brismar K, Sharp L, Langius-Eklöf A, Laurell G (2010) Explorative study on the predictive value of systematic inflammatory and metabolic markers on weight loss in head and neck cancer patients undergoing radiotherapy. Supportive Care in Cancer 18(11):1385-1391

WuY, Fu X, Zhu X, He X, Zou C, Han Y, Xu M, Huang C, Lu X, Zhao Y (2011) Prognostic role of systemic inflammatory response in renal cell carcinoma: a systematic review and meta-analysis. Journal of Cancer Research and Clinical Oncology 137(5):887-896

Chandrasekara S, Davis S, Thomson P, Haydon A (2018) High neutrophil‐to‐lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy. Asia‐pacific Journal of Clinical Oncology. 14(5):442-447

Kao SC, Vardy J, Harvie R, Chatfield M, van Zandwijk, N, Clarke S, Pavlakis N (2013) Health-related quality of life and inflammatory markers in malignant pleural mesothelioma. Supportive Care in Cancer 21(3):697-705

Gunduz S, Mutlu H, Tural D, Yıldız Ö, Uysal M, Coskun HS, Bozcuk H (2015) Platelet to lymphocyte ratio as a new prognostic for patients with metastatic renal cell cancer. Asia‐Pacific Journal of Clinical Oncology 11(4):288-292

Markus M, Abendroth A, Noureddine R, Paul A, Breitenbuecher S, Virchow I, Schmid KW, Markus P, Schumacher B, Wiesweg M, Wendling J, Mende B, Siveke JT, Schuler M, Kasper S (2021) Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy. Journal of Cancer Research and Clinical Oncology 147(2): 579-591

Lin GN, Peng JW, Liu PP, Liu DY, Xiao JJ, Chen XQ (2017) Elevated neutrophil‐to‐lymphocyte ratio predicts poor outcome in patients with advanced non‐small‐cell lung cancer receiving first‐line gefitinib or erlotinib treatment. Asia‐Pacific Journal of Clinical Oncology 13(5):189-194

Lee Y, Kim SH, Han JY, Kim HT, Yun T, Lee JS (2012) Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy. Journal of Cancer Research and Clinical Oncology 138(12):2009-2016

Tominaga T, Nonaka T, Hisanaga M, Fukuda A, Tanoue Y, Yoshimoto T, Hidaka S, Sawai T, Nagayasu T (2020) Prognostic value of the preoperative prognostic nutritional index in oldest-old patients with colorectal cancer. Surgery Today 50(5):449-459

Mohri Y, Inoue Y, Tanaka K, Hiro J, Uchida K, Kusunoki M (2013) Prognostic nutritional index predicts postoperative outcome in colorectal cancer. World Journal of Surgery 37(11):2688-2692

Verheul HM, Hoekman K, Lupu F, Broxterman HJ, van der Valk P, Kakkar AK, Pinedo HM (2000) Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. Clin Cancer Res 6:166–171

Ikeda M, Furukawa H, Imamura H, Shimizu J, Ishida H, Masutani S, Tatsuta M, Satomi T (2002) Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol. 9:287–291

Dubernard V, Arbeille BB, Lemesle MB, Legrand C (1997) Evidence for an alpha-granular pool of the cytoskeletal protein alpha-actinin in human platelets that redistributes with the adhesive glycoprotein thrombospondin-1 during the exocytotic process. Arterioscler Thromb Vasc Biol. 17:2293–2305

Galdiero MR, Bonavita E, Barajon I, Garlanda C, Mantovani A, Jaillon S (2013) Tumor associated macrophages and neutrophils in cancer. Immunobiology 218:1402–1410

Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539–545

Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH (2003) Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 6:283–287

Salazar-Onfray F, López MN, Mendoza-Naranjo A (2007) Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape. Cytokine Growth Factor Rev. 18:171–182

Bellone G, Turletti A, Artusio E, Mareschi K, Carbone A, Tibaudi D, Robecchi A, Emanuelli G, Rodeck U (1999) Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients. The American Journal of Pathology 155(2):537-547

Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137–148

Pedrazzani C, Mantovani G, Fernandes E, Bagante F, Luca Salvagno G, Surci N, Campagnaro T, Ruzzenente A, Danese E, Lippi G, Guglielmi A (2017) Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer. Sci Rep. 7(1):1494

Chan JC, Chan DL, Diakos CI, Engel A, Pavlakis N, Gill A, Clarke SJ (2017) The lymphocyte-to-monocyteratio is a superior predictor of overall survival in comparison toestablished biomarkers of resectable colorectal cancer. Ann Surg. 265(3):539-546

Park IJ, YouYN, Agarwal A, Skibber JM, Rodriguez-Bigas MA, Eng C, Feig BW, Das P, Krishnan S, Crane CH, Hu CY, Chang G J (2012) Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol. 30(15):1770–6

Lee IH, Hwang S, Lee SJ, Kang BW, Baek D, Kim HJ, Park SY, Park JS, Choi GS, Kim JC, Cho SH, Kim JG (2017) Systemic inflammatory response after preoperative chemoradiotherapy can affect oncologic outcomes in locally advanced rectal cancer. Anticancer Research 37(3):1459-1465

Hodek M, Sirák I, Ferko A, Örhalmi J, Hovorková E, Hadži Nikolov D, Paluska P, Kopecký J, Petera J, Vošmik M (2016) Neoadjuvant chemoradiotherapy of rectal carcinoma. Strahlentherapie und Onkologie 192(9):632-640